As of 2025-12-29, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 5.47 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -4.68 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.3x - 5.7x | 3.4x |
| Forward P/E multiples | 0.7x - 1.5x | 0.7x |
| Fair Price | (0.07) - (0.04) | (0.06) |
| Upside | -273.4% - -209.1% | -252.2% |
| Date | EV/EBITDA |
| 2025-12-22 | -1.17 |
| 2025-12-19 | -1.17 |
| 2025-12-18 | -1.49 |
| 2025-12-17 | -1.49 |
| 2025-12-16 | -1.17 |
| 2025-12-15 | -0.69 |
| 2025-12-12 | -0.69 |
| 2025-12-10 | -1.17 |
| 2025-12-09 | -1.01 |
| 2025-12-08 | -1.49 |
| 2025-12-05 | -1.49 |
| 2025-12-01 | -1.81 |
| 2025-11-28 | -1.65 |
| 2025-11-27 | -1.65 |
| 2025-11-21 | -2.29 |
| 2025-11-17 | -1.65 |
| 2025-11-13 | -2.76 |
| 2025-11-11 | -2.29 |
| 2025-11-10 | -2.45 |
| 2025-11-07 | -3.08 |
| 2025-10-30 | -0.37 |
| 2025-10-29 | -0.53 |
| 2025-10-28 | -0.53 |
| 2025-10-24 | -0.21 |
| 2025-10-07 | -0.37 |